Morepen Laboratories

Morepen Laboratories EBITDA per Employee

The EBITDA per Employee of Morepen Laboratories (MOREPENLAB.NS) as of Oct 25, 2026 is 1.06 M INR. In the previous year, EBITDA per Employee was 961,944.21 INR — a change of 9.74% (higher).

EBITDA per Employee

1.06 MINR

YoY

9.74%

Last updated:

EBITDA per Employee of Morepen Laboratories is 2025 1.06 M INR. EBITDA per Employee of Morepen Laboratories was 2024 961,944.21 INR. It decreases by 9.74% higher compared to the previous year.

The Morepen Laboratories EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
392,392.36 INR
Jan 1, 2019
409,429.35 INR
Jan 1, 2020
415,455.43 INR
Jan 1, 2021
718,804.12 INR
Jan 1, 2022
828,562.16 INR
Jan 1, 2023
482,311.10 INR
Jan 1, 2024
961,944.21 INR
Jan 1, 2025
1.06 M INR
The Morepen Laboratories EBITDA per Employee history
YEAREBITDA per EmployeeYoY
1.06 MINR+9.74%
961,944.21INR+99.44%
482,311.10INR-41.79%
828,562.16INR+15.27%
718,804.12INR+73.02%
415,455.43INR+1.47%
409,429.35INR+4.34%
392,392.36INR+5.43%
372,197.70INR+7.36%
346,675.56INR+16.53%
297,497.88INR+0.06%
297,331.72INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Morepen Laboratories Stock analysis

What does Morepen Laboratories do? Morepen Laboratories Ltd. generates revenue through the manufacturing and marketing of bulk drugs, pharmaceutical formulations, and home health products. The company produces active pharmaceutical ingredients (APIs) such as Apixaban, Edoxaban, Sitagliptin, and Rivaroxaban, which are sold to other pharmaceutical manufacturers. Its finished formulations, including Intebact Capsules, Intelicaps Lax, and Rythmix Kid Syrup, are marketed under its own brand for direct consumer sales. Home health products like the Dr. Morepen 49W Room Air Purifier and Dr. Morepen VP06 Breathe Free Vaporizer are sold directly to consumers through retail channels. The company's subsidiaries, Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited, support these product lines by handling specific manufacturing and distribution tasks. The primary customers for APIs are pharmaceutical companies seeking bulk ingredients for their own formulations. Finished formulations target healthcare consumers and pharmacies, while home health products are sold to households and medical facilities. The company's product segments are clearly divided: APIs for industrial clients, branded formulations for retail consumers, and home health devices for personal use. This segmentation allows Morepen to serve multiple market segments without overlapping product lines. Morepen's revenue streams are diversified across three main areas: API sales to pharmaceutical manufacturers, direct-to-consumer sales of branded formulations, and retail sales of home health products. The company's subsidiaries play a key role in supporting each segment, with Dr. Morepen Limited handling branded formulations, Morepen Devices Limited managing home health devices, and Total Care Limited likely supporting broader healthcare services. This structure ensures that each product line is efficiently managed and marketed to its respective target audience. Morepen Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Morepen Laboratories stock

EBITDA per Employee of Morepen Laboratories is 1.06 M INR in 2025.

EBITDA per Employee of Morepen Laboratories changed from 961,944.21 INR to 1.06 M INR, representing a 9.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Morepen Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Morepen Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Morepen Laboratories

All Key Metrics — Morepen Laboratories